Minerva Neurosciences, Inc. Shares Outstanding (Cover Page)
Minerva Neurosciences, Inc. (NERV) had Shares Outstanding (Cover Page) of 47.75 million shares as of 2026-08-04, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-07
- 2026-08-04: Entity Common Stock, Shares Outstanding 47.75M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 46.59M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 43.27M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 6.99M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-04 | 47.75M shares 10-Q · filed 2026-08-07 |
| 2026-04-30 | 46.59M shares 10-Q · filed 2026-05-05 |
| 2026-03-06 | 43.27M shares 10-K · filed 2026-03-11 |
| 2025-10-31 | 6.99M shares 10-Q · filed 2025-11-05 |
| 2025-08-08 | 6.99M shares 10-Q · filed 2025-08-14 |
| 2025-05-08 | 6.99M shares 10-Q · filed 2025-05-13 |
| 2025-04-18 | 6.99M shares 10-K/A · filed 2025-04-29 |
| 2025-02-20 | 6.99M shares 10-K · filed 2025-02-25 |
| 2024-10-31 | 6.99M shares 10-Q · filed 2024-11-05 |
| 2024-08-01 | 6.99M shares 10-Q · filed 2024-08-06 |
| 2024-04-26 | 6.99M shares 10-Q · filed 2024-05-01 |
| 2024-04-12 | 6.99M shares 10-K/A · filed 2024-04-22 |
| 2024-02-19 | 6.99M shares 10-K/A · filed 2024-02-26 |
| 2023-11-02 | 6.99M shares 10-Q · filed 2023-11-07 |
| 2023-07-27 | 6.99M shares 10-Q · filed 2023-08-01 |
| 2023-05-10 | 5.57M shares 10-Q · filed 2023-05-15 |
| 2023-04-17 | 5.34M shares 10-K/A · filed 2023-04-20 |
| 2023-03-03 | 5.34M shares 10-K · filed 2023-03-08 |
| 2022-11-04 | 5.34M shares 10-Q · filed 2022-11-09 |
| 2022-08-04 | 5.34M shares 10-Q · filed 2022-08-09 |
| 2022-04-29 | 42.72M shares 10-Q · filed 2022-05-04 |
| 2022-02-24 | 42.72M shares 10-K · filed 2022-03-01 |
| 2021-11-03 | 42.72M shares 10-Q · filed 2021-11-08 |
| 2021-07-28 | 42.72M shares 10-Q · filed 2021-08-02 |
| 2021-05-07 | 42.72M shares 10-Q · filed 2021-05-12 |
| 2021-03-04 | 42.72M shares 10-K · filed 2021-03-08 |
| 2020-10-28 | 42.67M shares 10-Q · filed 2020-11-02 |
| 2020-07-29 | 41.20M shares 10-Q · filed 2020-08-03 |
| 2020-04-29 | 39.22M shares 10-Q · filed 2020-05-04 |
| 2020-03-05 | 39.22M shares 10-K · filed 2020-03-09 |
| 2019-10-30 | 39.03M shares 10-Q · filed 2019-11-04 |
| 2019-07-31 | 39.03M shares 10-Q · filed 2019-08-05 |
| 2019-05-01 | 39.03M shares 10-Q · filed 2019-05-06 |
| 2019-03-07 | 39.03M shares 10-K · filed 2019-03-12 |
| 2018-10-31 | 38.87M shares 10-Q · filed 2018-11-05 |
| 2018-07-31 | 38.77M shares 10-Q · filed 2018-08-02 |
| 2018-05-01 | 38.75M shares 10-Q · filed 2018-05-03 |
| 2018-03-09 | 38.75M shares 10-K · filed 2018-03-12 |
| 2017-10-31 | 38.70M shares 10-Q · filed 2017-11-06 |
| 2017-07-31 | 42.51M shares 10-Q · filed 2017-08-03 |
| 2017-05-01 | 36.70M shares 10-Q · filed 2017-05-04 |
| 2017-03-10 | 35.29M shares 10-K · filed 2017-03-13 |
| 2016-10-28 | 34.81M shares 10-Q · filed 2016-11-03 |
| 2016-07-29 | 34.81M shares 10-Q · filed 2016-08-04 |
| 2016-04-28 | 27.94M shares 10-Q · filed 2016-05-03 |
| 2016-03-09 | 27.76M shares 10-K · filed 2016-03-14 |
| 2015-10-30 | 24.72M shares 10-Q · filed 2015-11-05 |
| 2015-07-31 | 24.72M shares 10-Q · filed 2015-08-05 |
| 2015-04-22 | 24.72M shares 10-Q · filed 2015-05-07 |
| 2015-03-20 | 24.72M shares 10-K · filed 2015-03-26 |
| 2014-11-05 | 18.44M shares 10-Q · filed 2014-11-06 |
| 2014-08-06 | 18.44M shares 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |